Minimally-Invasive Secondary Cytoreduction in Recurrent Ovarian Cancer

The role of secondary cytoreductive surgery (SCS) in the treatment of recurrent ovarian cancer (ROC) has been widely increased in recent years, especially in trying to improve the quality of life of these patients by utilising a minimally-invasive (MI) approach. However, surgery in previously-treate...

Full description

Bibliographic Details
Main Authors: Camilla Certelli, Silvio Andrea Russo, Luca Palmieri, Aniello Foresta, Luigi Pedone Anchora, Virginia Vargiu, Francesco Santullo, Anna Fagotti, Giovanni Scambia, Valerio Gallotta
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/19/4769
_version_ 1797576073047703552
author Camilla Certelli
Silvio Andrea Russo
Luca Palmieri
Aniello Foresta
Luigi Pedone Anchora
Virginia Vargiu
Francesco Santullo
Anna Fagotti
Giovanni Scambia
Valerio Gallotta
author_facet Camilla Certelli
Silvio Andrea Russo
Luca Palmieri
Aniello Foresta
Luigi Pedone Anchora
Virginia Vargiu
Francesco Santullo
Anna Fagotti
Giovanni Scambia
Valerio Gallotta
author_sort Camilla Certelli
collection DOAJ
description The role of secondary cytoreductive surgery (SCS) in the treatment of recurrent ovarian cancer (ROC) has been widely increased in recent years, especially in trying to improve the quality of life of these patients by utilising a minimally-invasive (MI) approach. However, surgery in previously-treated patients may be challenging, and patient selection and surgical planning are crucial. Unfortunately, at the moment, validated criteria to select patients for MI-SCS are not reported, and no predictors of its feasibility are currently available, probably due to the vast heterogeneity of recurrence patterns. The aim of this narrative review is to describe the role of secondary cytoreductive surgery and, in particular, minimally-invasive procedures, in ROC, analyzing patient selection, outcomes, criticisms, and future perspectives.
first_indexed 2024-03-10T21:47:18Z
format Article
id doaj.art-1c939926e0a042c38244f44ee5104d40
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T21:47:18Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-1c939926e0a042c38244f44ee5104d402023-11-19T14:10:18ZengMDPI AGCancers2072-66942023-09-011519476910.3390/cancers15194769Minimally-Invasive Secondary Cytoreduction in Recurrent Ovarian CancerCamilla Certelli0Silvio Andrea Russo1Luca Palmieri2Aniello Foresta3Luigi Pedone Anchora4Virginia Vargiu5Francesco Santullo6Anna Fagotti7Giovanni Scambia8Valerio Gallotta9Gynecologic Oncology Unit, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, ItalyGynecologic Oncology Unit, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, ItalyGynecologic Oncology Unit, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, ItalyGynecologic Oncology Unit, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, ItalyGynecologic Oncology Unit, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, ItalyGynecologic Oncology Unit, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, ItalySurgical Unit of Peritoneum and Retroperitoneum, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, ItalyGynecologic Oncology Unit, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, ItalyGynecologic Oncology Unit, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, ItalyGynecologic Oncology Unit, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, ItalyThe role of secondary cytoreductive surgery (SCS) in the treatment of recurrent ovarian cancer (ROC) has been widely increased in recent years, especially in trying to improve the quality of life of these patients by utilising a minimally-invasive (MI) approach. However, surgery in previously-treated patients may be challenging, and patient selection and surgical planning are crucial. Unfortunately, at the moment, validated criteria to select patients for MI-SCS are not reported, and no predictors of its feasibility are currently available, probably due to the vast heterogeneity of recurrence patterns. The aim of this narrative review is to describe the role of secondary cytoreductive surgery and, in particular, minimally-invasive procedures, in ROC, analyzing patient selection, outcomes, criticisms, and future perspectives.https://www.mdpi.com/2072-6694/15/19/4769recurrent ovarian cancersecondary cytoreductive surgeryminimally-invasive surgeryrobotic surgerylaparoscopic surgery
spellingShingle Camilla Certelli
Silvio Andrea Russo
Luca Palmieri
Aniello Foresta
Luigi Pedone Anchora
Virginia Vargiu
Francesco Santullo
Anna Fagotti
Giovanni Scambia
Valerio Gallotta
Minimally-Invasive Secondary Cytoreduction in Recurrent Ovarian Cancer
Cancers
recurrent ovarian cancer
secondary cytoreductive surgery
minimally-invasive surgery
robotic surgery
laparoscopic surgery
title Minimally-Invasive Secondary Cytoreduction in Recurrent Ovarian Cancer
title_full Minimally-Invasive Secondary Cytoreduction in Recurrent Ovarian Cancer
title_fullStr Minimally-Invasive Secondary Cytoreduction in Recurrent Ovarian Cancer
title_full_unstemmed Minimally-Invasive Secondary Cytoreduction in Recurrent Ovarian Cancer
title_short Minimally-Invasive Secondary Cytoreduction in Recurrent Ovarian Cancer
title_sort minimally invasive secondary cytoreduction in recurrent ovarian cancer
topic recurrent ovarian cancer
secondary cytoreductive surgery
minimally-invasive surgery
robotic surgery
laparoscopic surgery
url https://www.mdpi.com/2072-6694/15/19/4769
work_keys_str_mv AT camillacertelli minimallyinvasivesecondarycytoreductioninrecurrentovariancancer
AT silvioandrearusso minimallyinvasivesecondarycytoreductioninrecurrentovariancancer
AT lucapalmieri minimallyinvasivesecondarycytoreductioninrecurrentovariancancer
AT anielloforesta minimallyinvasivesecondarycytoreductioninrecurrentovariancancer
AT luigipedoneanchora minimallyinvasivesecondarycytoreductioninrecurrentovariancancer
AT virginiavargiu minimallyinvasivesecondarycytoreductioninrecurrentovariancancer
AT francescosantullo minimallyinvasivesecondarycytoreductioninrecurrentovariancancer
AT annafagotti minimallyinvasivesecondarycytoreductioninrecurrentovariancancer
AT giovanniscambia minimallyinvasivesecondarycytoreductioninrecurrentovariancancer
AT valeriogallotta minimallyinvasivesecondarycytoreductioninrecurrentovariancancer